Equity Overview
Price & Market Data
Price: $21.29
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,393,796,480
Daily Volume: 0
Performance Metrics
1 Week: 11.82%
1 Month: 15.27%
3 Months: 32.15%
6 Months: 24.94%
1 Year: 123.9%
YTD: 26.50%
Company Details
Employees: 103
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.